During the past decade, Dermatovenerologicka klinika 3. LF UK a FNKV conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatovenerologicka klinika 3. LF UK a FNKV" #1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dermatovenerologicka klinika 3. LF UK a FNKV" are "Melanoma" (3 trials) and "Skin Cancer" (1 trials). Many other conditions were trialed in "Dermatovenerologicka klinika 3. LF UK a FNKV" in a lesser frequency.

Most popular intervention types in "Dermatovenerologicka klinika 3. LF UK a FNKV" are "Biological" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (2 trials), "BMS-986205" (1 trials), "NKTR-214" (1 trials), "Placebo" (1 trials) and "ipilimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dermatovenerologicka klinika 3. LF UK a FNKV" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dermatovenerologicka klinika 3. LF UK a FNKV". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dermatovenerologicka klinika 3. LF UK a FNKV, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dermatovenerologicka klinika 3. LF UK a FNKV, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".